Skip to main navigation
Skip to search
Skip to main content
Sefako Makgatho Health Sciences University Home
Home
Profiles
Departments
Research output
Activities
Search by expertise, name or affiliation
To clot, or not to clot – antithrombotic therapy is the question
E. Osuch
, A. Marais
*
*
Corresponding author for this work
Research output
:
Contribution to journal
›
Article
›
peer-review
1
Citation (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'To clot, or not to clot – antithrombotic therapy is the question'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Thrombosis
100%
Clot
100%
Antithrombotic Therapy
100%
Treatment Options
50%
Inappropriate Use
50%
Venous Thromboembolism
50%
Individual Risk
50%
Hemostasis
50%
Clot Lysis
50%
Characteristic Risk
50%
Vitamin K Antagonists
50%
Anticoagulants
50%
Pharmacological Management
50%
Thrombin
50%
Coagulation Cascade
50%
Anticoagulation Agents
50%
Antiplatelet Agents
50%
Clot Formation
50%
Individual Benefits
50%
Anticoagulation Treatment
50%
Factor Xa
50%
Blood Platelets
50%
Arterial Thrombosis
50%
Vascular Endothelial
50%
Physiologic
50%
Antithrombotic Agents
50%
Enzymatic Activity
50%
Fibrinolytic Agents
50%
Medicine and Dentistry
Thrombosis
100%
Antithrombotic Therapy
100%
Venous Thromboembolism
50%
Antithrombotic
50%
Enzyme Activity
50%
Hemostat
50%
Blood Stasis
50%
Anticoagulation
50%
Vitamin K Antagonist
50%
Anticoagulant
50%
Blood Clotting
50%
Artery Thrombosis
50%
Antiplatelet Drug
50%
Platelet
50%
Blood Clot Lysis
50%
Antithrombotic Agent
50%
Thrombolytic Drug
50%
Prothrombinase
50%
Thrombin
50%
Neuroscience
Antithrombotic
100%
Vitamin K Antagonist
50%
Blood Clotting Factor 10a
50%
Enzyme Activity
50%
Antithrombotic Agents
50%
Coagulation System
50%
Thrombin
50%
Hemostasis
50%
Thrombolytic Drug
50%
Antiplatelet Drug
50%
Platelet
50%
Pharmacology, Toxicology and Pharmaceutical Science
Anticoagulant Agent
100%
Antithrombotic Therapy
100%
Thrombosis
66%
Venous Thromboembolism
33%
Hemostatic Agent
33%
Blood Stasis
33%
Antivitamin K
33%
Artery Thrombosis
33%
Blood Clotting Factor 10a
33%
Fibrinolytic Agent
33%
Thrombin
33%
Antithrombocytic Agent
33%